XML 76 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income per Common Share
9 Months Ended
Sep. 28, 2014
Net Income per Common Share

L. Net Income per Common Share

The following table sets forth the computation of basic and diluted net income per common share:

 

     For the Three Months
Ended
     For the Nine Months
Ended
 
     September 28,
2014
     September 29,
2013
     September 28,
2014
     September 29,
2013
 
     (in thousands, except per share amounts)  

Net income for basic and diluted net income per share

   $ 82,949       $ 69,459       $ 185,083       $ 142,604   
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average common shares-basic

     207,381         191,307         198,367         190,521   

Effect of dilutive potential common shares:

           

Incremental shares from assumed conversion of convertible notes (1)

     —           23,257         6,684         23,303   

Convertible note hedge warrant shares (2)

     8,885         18,678         16,744         18,742   

Restricted stock units

     1,167         1,102         975         1,000   

Stock options

     879         1,465         997         1,564   

Employee stock purchase rights

     21         19         28         35   
  

 

 

    

 

 

    

 

 

    

 

 

 

Dilutive potential common shares

     10,952         44,521         25,428         44,644   
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average common shares-diluted

     218,333         235,828         223,795         235,165   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income per common share-basic

   $ 0.40       $ 0.36       $ 0.93       $ 0.75   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income per common share-diluted

   $ 0.38       $ 0.29       $ 0.83       $ 0.61   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

Incremental shares from conversion of the convertible notes for the nine months ended September 28, 2014 were calculated using the difference between the average Teradyne stock price from January 1, 2014 through March 12, 2014 and the conversion price of $5.4750, multiplied by 34.7 million shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period from January 1, 2014 to March 12, 2014 and adjusted for the number of days the convertible notes were outstanding. Incremental shares from assumed conversion of the convertible notes for the three and nine months ended September 29, 2013 were calculated using the difference between the average Teradyne stock price for the period the convertible notes were outstanding and the conversion price of $5.48, multiplied by the 34.7 million shares to be issued upon conversion. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.

(2) Convertible note hedge warrant shares for the three and nine months ended September 28, 2014 are calculated using the difference between the average Teradyne stock price for the period the warrants were outstanding and the warrant price of $7.63 and $7.64, respectively, multiplied by the weighted average warrant shares outstanding. The result of this calculation, representing the total intrinsic value of the warrant, is divided by the average Teradyne stock price for the period the warrants were outstanding. Convertible note hedge warrant shares for the three and nine months ended September 29, 2013 are calculated using the difference between the average Teradyne stock price for the period and the warrant price of $7.67, multiplied by the 34.7 million shares that would be issued upon conversion. The result of this calculation, representing the total intrinsic value of the warrant, is divided by the average Teradyne stock price for the period.

The computation of diluted net income per common share for the three and nine months ended September 28, 2014 excludes the effect of the potential exercise of stock options to purchase approximately 0.3 million shares because the effect would have been anti-dilutive.

The computation of diluted net income per common share for the three and nine months ended September 29, 2013 excludes the effect of the potential exercise of stock options to purchase approximately 0.4 million shares because the effect would have been anti-dilutive.